Compare SPH & TNDM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | SPH | TNDM |
|---|---|---|
| Founded | 1945 | 2006 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Other Specialty Stores | Medical/Dental Instruments |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.3B | 1.4B |
| IPO Year | 1996 | 2013 |
| Metric | SPH | TNDM |
|---|---|---|
| Price | $19.83 | $14.79 |
| Analyst Decision | | Buy |
| Analyst Count | 0 | 19 |
| Target Price | N/A | ★ $28.00 |
| AVG Volume (30 Days) | 113.4K | ★ 2.0M |
| Earning Date | 05-07-2026 | 05-07-2026 |
| Dividend Yield | ★ 6.63% | N/A |
| EPS Growth | ★ 42.11 | N/A |
| EPS | ★ 2.75 | N/A |
| Revenue | ★ $1,432,518,000.00 | $1,014,736,000.00 |
| Revenue This Year | $2.06 | $8.11 |
| Revenue Next Year | $1.64 | $11.85 |
| P/E Ratio | $28.68 | ★ N/A |
| Revenue Growth | ★ 7.94 | 7.93 |
| 52 Week Low | $17.30 | $10.00 |
| 52 Week High | $20.80 | $29.65 |
| Indicator | SPH | TNDM |
|---|---|---|
| Relative Strength Index (RSI) | 52.96 | 29.09 |
| Support Level | $18.04 | $13.24 |
| Resistance Level | $20.52 | $15.75 |
| Average True Range (ATR) | 0.55 | 1.39 |
| MACD | 0.05 | -0.48 |
| Stochastic Oscillator | 63.94 | 7.26 |
Suburban Propane Partners LP distributes propane, renewable propane, renewable natural gas (RNG), fuel oil, refined fuels, and markets natural gas and electricity in deregulated markets. It produces and invests in low-carbon fuel alternatives. The company installs and services home comfort heating and ventilation equipment and distributes fuel oil, kerosene, diesel, and gasoline to about 25,000 residential and commercial customers mainly in the U.S. northeast. It operates three segments: Propane, Fuel Oil and Refined Fuels, and Natural Gas and Electricity, with the Propane segment generating the majority of revenue. Propane, a by-product of natural gas processing and petroleum refining, is a clean-burning energy source known for transportability and ease of use.
Tandem Diabetes designs, manufactures, and markets durable insulin pumps for individuals with diabetes. The firm first entered this market in 2012 and has since introduced multiple generations of pumps leading to its current t:slim X2 device. The firm recently launched its smaller Mobi pump and continues to work on Tobi (a tubeless version of Mobi), and the Sigi tubeless patch pump. Nearly three-quarters of total revenue is derived from the US, with the remainder primarily from other developed nations. The pumps themselves generate just over half of total sales, and another one-third is from disposable infusion sets that need to be changed over every 2 to 3 days.